Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
3-D Matrix, Ltd. (7777.T)
JPY367.00
+15.00 (+4.26%)
JP JPX Healthcare Medical - Devices
Address
Kojimachi HF Building 102-0083
Tokyo, JP
Tokyo, JP
CEO
Jun Okada
Website
3d-matrix.co.jp
IPO
2011-10-24
ISIN JP3410730000
Also trades on
Other OTC · DMTRF (USD)
Tokyo Stock Exchange · 7777.T (JPY)
Description
3-D Matrix, Ltd. specializes in pioneering self-assembling peptide technology. Its flagship product, PuraMatrix, is an innovative self-assembling peptide hydrogel with diverse applications across medical fields, including regenerative medicine, cell therapy, advanced drug delivery systems, and surgical interventions. This Tokyo-based firm was established in 2004.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY367.00
+15.00 (+4.26%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4M
Beta
0.99
Float Shares
115.89M
Free Float %
96.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -18.22% | -23.29% | -25.67% | -49.93% | -3.23% | -1.10% | +124.38% | +88.95% | +26.86% | -63.96% | +10.04% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
367.00
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
8.35
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+57.0% ★ Q2'26: +88.8% (vs Q2'25)
-
EPS growth Medical - Devices: +28.5%+222.9% ★ Q2'26: +224.2% (vs Q2'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+6.7% Q2'26: +0.0% (vs Q2'25)
-
EBIT margin Medical - Devices: +6.2%+12.3% ★ Q2'26: +17.8% (vs Q2'25)
-
ROIC Medical - Devices: +3.3%+29.3% ★ Q2'26: +55.1% (vs Q2'25)
-
Share dilution Medical - Devices: 0.0%+35.4% Q2'26: +31.1% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×0.45× ★ Q2'26: 0.24× (vs Q2'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Apr 2015 actual |
Apr 2016 actual |
Apr 2017 actual |
Apr 2018 actual |
Apr 2019 actual |
Apr 2020 actual |
Apr 2021 actual |
Apr 2022 actual |
Apr 2023 actual |
Apr 2024 actual |
Apr 2025 actual |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
99.78M
est: 50.00M (+99.6%)
|
141.83M
est: 130.00M (+9.1%)
|
615.85M
est: 600.00M (+2.6%)
|
228.62M
est: 220.00M (+3.9%)
|
328.85M
est: 1.10B (-70.1%)
|
672.42M
est: 870.00M (-22.7%)
|
1.02B
est: 1.20B (-14.6%)
|
1.51B
est: 1.50B (+0.4%)
|
2.31B
est: 2.70B (-14.3%)
|
4.59B
est: 4.10B (+11.9%)
|
6.93B
est: 6.93B (+0.0%)
|
| EBITDA |
-1.86B
est: 11.58M (-16,161.1%)
|
-2.36B
est: 30.10M (-7,944.4%)
|
-1.26B
est: 138.91M (-1,010.0%)
|
10.00M
est: 50.93M (-80.4%)
|
-285.00M
est: 254.66M (-211.9%)
|
-559.00M
est: 201.42M (-377.5%)
|
638.00M
est: 277.82M (+129.6%)
|
843.00M
est: 347.27M (+142.8%)
|
715.00M
est: 625.09M (+14.4%)
|
59.13M
est: 949.20M (-93.8%)
|
-2.40B
est: 1.61B (-249.8%)
|
| EBIT |
-1.98B
est: -37.95M (-5,121.8%)
|
-2.46B
est: -98.68M (-2,390.3%)
|
-1.39B
est: -455.43M (-204.2%)
|
-1.86B
est: -166.99M (-1,011.6%)
|
-2.54B
est: -834.95M (-204.8%)
|
-3.09B
est: -660.37M (-367.6%)
|
-2.01B
est: -910.86M (-120.3%)
|
-1.89B
est: -1.14B (-65.9%)
|
-2.38B
est: -2.05B (-16.3%)
|
59.13M
est: -3.11B (+101.9%)
|
-2.40B
est: -5.26B (+54.3%)
|
| Net Income |
-1.99B
est: -9.62B (+79.3%)
|
-2.46B
est: -11.07B (+77.8%)
|
-1.39B
est: -5.97B (+76.7%)
|
-1.87B
est: -7.84B (+76.2%)
|
-2.55B
est: -4.20B (+39.1%)
|
-3.10B
est: -6.11B (+49.4%)
|
-2.01B
est: -5.37B (+62.5%)
|
-1.89B
est: -5.20B (+63.6%)
|
-2.45B
est: -3.18B (+23.0%)
|
-255.51M
est: -1.27B (+79.9%)
|
-2.50B
|
| SGA |
1.19B
est: 73.90M (+1,503.6%)
|
1.18B
est: 192.14M (+515.0%)
|
1.29B
est: 886.81M (+44.9%)
|
1.36B
est: 325.17M (+319.4%)
|
1.50B
est: 1.63B (-7.9%)
|
1.85B
est: 1.29B (+43.6%)
|
2.17B
est: 1.77B (+22.2%)
|
2.71B
est: 2.22B (+22.4%)
|
4.00B
est: 3.99B (+0.1%)
|
4.65B
est: 6.06B (-23.3%)
|
5.08B
est: 10.25B (-50.4%)
|
| EPS |
-94.89
est: -96.90 (+2.1%)
|
-114.49
est: -111.50 (-2.7%)
|
-64.62
est: -60.20 (-7.3%)
|
-81.26
est: -79.00 (-2.9%)
|
-97.41
est: -42.30 (-130.3%)
|
-103.36
est: -61.60 (-67.8%)
|
-49.65
est: -54.10 (+8.2%)
|
-37.20
est: -52.40 (+29.0%)
|
-40.64
est: -32.00 (-27.0%)
|
-3.49
est: -12.80 (+72.7%)
|
-25.20
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-06-11 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-10 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-09 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-08 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-05 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-04 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-03 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-02 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-01 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-29 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-28 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-27 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-25 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | B- | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
6.53M
OE per share TTM
0.08
Owner's Yield
0.01%
Maintenance CapEx ratio
0.10%
Maint CapEx / Avg PPE
0.1%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares International Small-Cap Equity Factor ETF ISCF | 0.01% | 95.6K | 0.24% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
12.60M
Shares Outstanding
120.21M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hisato Yuto | Executive Officer | — | male |
| Jun Okada | President, Chief Executive Officer & Representative Director | — | male |
| Keiji Nagano | Executive Chairman of the Board | — | male |
| Satoru Kobayashi | Executive Officer, Head of Business Development & Director | — | male |
| Shuguang Zhang | Founder | — | — |
| Toshi Amanuma | Representative Director, President & Director | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7777.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
